Editorial: New opportunities in drug design for the management and treatment of type 2 diabetes

Frontiers in Pharmacology

Pharmacology

Teodorico C. Ramalho¹  Jelena B. Popović-Djordjević²  Hari Prasad Devkota³  Hassan Rasouli⁴ 

[1] Department of Chemistry, Federal University of Larvas, Larvas, Brazil;Department of Food Technology and Biochemistry, Faculty of Agriculture, University of Belgrade, Belgrade, Serbia;Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan;Medical Biology Research Center (MBRC), Kermanshah University of Medical Sciences, Kermanshah, Iran;Department of Chemistry, Federal University of Larvas, Larvas, Brazil;

关键词: drug design;    diabetes mellitus;    type 2 diabetes;    inhibitor;    hypoglycemic agents;   

DOI  :  10.3389/fphar.2023.1187057

 received in 2023-03-15, accepted in 2023-03-31,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Rasouli, Ramalho, Popović-Djordjević and Devkota.